Strength and course of the SARS CoV-specific immune response after infectio

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00023047
• Lead Sponsor: Institut für Medizinische Mikrobiologie und Virologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-09-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

Adults with previous SARS CoV-2 infection

Exclusion Criteria

Pregnancy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The study measures the immune response to SARS CoV-2

Secondary Outcome Measures

Name	Time	Method
o endpoint